Targeted Multifunctional Nanoplatform for Imaging-Guided Precision Diagnosis and Photothermal/Photodynamic Therapy of Orthotopic Hepatocellular Carcinoma
Shuo Qi,Gongyuan Liu,Jiangbo Chen,Peng Cao,Xiaohua Lei,Chengming Ding,Guodong Chen,Yachao Zhang,Lidai Wang
DOI: https://doi.org/10.2147/IJN.S377080
IF: 7.033
2022-08-31
International Journal of Nanomedicine
Abstract:Shuo Qi, 1– 3, &ast Gongyuan Liu, 4 Jiangbo Chen, 2, 3 Peng Cao, 1 Xiaohua Lei, 1 Chengming Ding, 1 Guodong Chen, 1, &ast Yachao Zhang, 2, 3 Lidai Wang 2, 3 1 Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, People's Republic of China; 2 Department of Biomedical Engineering, City University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China; 3 Department of Biomedical Engineering, City University of Hong Kong Shenzhen Research Institute, Shenzhen, People's Republic of China; 4 Department of Chemistry, City University of Hong Kong, Hong Kong Special Administrative Region, Peoples's Republic of China &astThese authors contributed equally to this work Correspondence: Yachao Zhang; Lidai Wang, Email ; Background: Effective theranostic of hepatocellular carcinoma (HCC) in an early-stage is imminently demanded to improve its poor prognosis. Combination of the near-infrared (NIR) photoacoustic imaging (PAI) and fluorescence imaging (FLI) can provide high temporospatial resolution, outstanding optical contrast, and deep penetration and thus is promising for accurate and sensitive HCC diagnosis. Methods: A versatile CXCR4-targeted Indocyanine green (ICG)/Platinum (Pt)-doped polydopamine melanin-mimic nanoparticle (designated ICG/, referred to as IPP-c) is synthesized as an HCC-specific contrast agent for high-resolution precise diagnostic PAI/FLI and optical imaging-guided targeted photothermal therapy (PTT)/photodynamic therapy (PDT) of orthotopic small hepatocellular carcinoma (SHCC). Results: The multifunctional targeted nanoparticle yields superior HCC specificity, high imaging contrast in both PAI and FLI, good stability, reliable biocompatibility, effective singlet oxygen generation and superior photothermal conversion efficiency (PCE, 58.7%) upon 808-nm laser irradiation. The targeting ability of IPP-c was validated in in vitro experiments on selectively killing the CXCR4-overexpressing HCC cells. Moreover, we test the efficient dual-modal optical precision diagnosis properties of IPP-c via in vivo experiments on targeted particle accumulation in an early-stage SHCC mouse model (tumor diameter about 1.2 mm). Then, under the guidance of real-time optical imaging, effective and mini-invasive PTT/PDT of orthotopic SHCCs were demonstrated without damaging adjacent liver tissues or other major organs. Conclusion: This study presented a multifunctional CXCR4-targeted nanoparticle to conduct effective and mini-invasive phototherapeutics of orthotopic SHCCs via the real-time quantitative guidance by optical imaging, which provided a new perception for building a versatile targeted nanoplatform for phototheranostics of early-stage HCC. Keywords: hepatocellular carcinoma, CXCR4-targeted, photoacoustic imaging, photothermal therapy, photodynamic therapy Hepatocellular carcinoma, with a 5-year survival rate lower than 18%, 1–3 is one of the most prevalent causal factors of cancer deaths worldwide. Due to the absence of early diagnosis and effective treatment, most patients lost the chance of radical cure due to the advanced-stage diagnosis. 4,5 Due to either low sensitivity or inadequate penetration depth, the early sensitive diagnosis of small hepatocellular carcinoma (SHCC) is still challenging in clinic. Ultrasound (US) imaging, X-ray computed tomography (CT) and magnetic resonance (MR) imaging are commonly used in clinical practice to image solid tumors in deep tissues. 6–8 However, these technologies are not sensitive enough to detect millimeter-sized SHCC lesions. Optical imaging has received broad attention for its biosafety, high sensitivity, and molecular imaging capabilities, which enables accurate diagnosis of early-stage HCC. Recently, near-infrared (NIR) photoacoustic imaging (PAI) and fluorescence imaging (FLI) have been developed for early tumor detection and diagnosis. 9–12 Because PAI offers high imaging resolution in deep tissue and FLI provides high imaging sensitivity, the combination of the two modalities can accurately detect exogenous and endogenous contrasts including oxygen saturation, lipids, hemoglobin concentration, and a variety of molecules and nanoparticles. 13–17 Meanwhile, due to the high photothermal conversion efficiency (PCE) and efficient reactive oxygen species (ROS) generation of some optical contrast agents, the combination of photothermal therapy (PTT)/photodynamic therapy (PDT) can be readily co-implemented under the real-time g -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology